Translational Transplantation Tolerance Cooperative Study Group
Funds a multi-center group translating transplant tolerance regimens toward the clinic, so grafts survive without lifelong immune-suppressing drugs.
About
Organ transplant recipients normally take immune-suppressing drugs for life, with all the infection and cancer risk that carries. This group exists to make that unnecessary, by getting tolerance regimens out of the lab and into people.
The goal is stated directly: facilitate clinical translation of safe and effective transplant tolerance regimens that achieve long-term graft survival without life…
Biotech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.